Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Diabetes Reports
Published in: Current Diabetes Reports 7/2014

01-07-2014 | Obesity (J McCaffery, Section Editor)

Obesity and Type 2 Diabetes in Sub-Sahara Africa

Authors: Jean Claude Mbanya, Felix K. Assah, Jude Saji, Emmanuella N. Atanga

Published in: Current Diabetes Reports | Issue 7/2014

Login to get access

Abstract

There is a mounting body of evidence regarding the challenge posed by diabetes and obesity on the health systems of many Sub-Sahara African countries. This trend has been linked to the changing demographic profile together with rapid urbanization and changing lifestyles in both rural and urban settings in Africa. Africa is expected to witness the greatest increase in the number of people with diabetes from 19.8 million in 2013 to 41.4 million in 2035 if current trends persist. Excess weight alone currently accounts for at least 2.8 million deaths globally each year through increased risk for type 2 diabetes and cardiovascular complications. This review highlights recent literature on the problem of obesity and type 2 diabetes in Sub-Sahara Africa. It exposes the need for concrete interventions based on the now available wealth of evidence.
Literature
1.
UNAIDS. Report on the global AIDS epidemic. Geneva: UNAIDS; 2010.
2.
World Health Organisation. WHO global tuberculosis control report. Geneva: WHO; 2010.
3.
Saydah SH, Eberhardt MS, Loria CM, Brancati FL. Age and the burden of death attributable to diabetes in the United States. Am J Epidemiol. 2002;156:714–9.
4.••
International Diabetes Federation. IDF diabetes atlas. 6th ed. Brussels: International Diabetes Federation; 2013. Presents the most current global updates on diabetes. Published by the International Diabetes Federation.
5.
Gwatkin D, Guillot M, Heuveline P. The burden of disease among the global poor. Lancet. 1999;354:586–9.PubMedCrossRef
6.
World Health organization (WHO). Global health risks: mortality and burden of disease attributable to selected major risks. Geneva: World Health Organization; 2009.
7.
WHO. Definition, diagnosis and classification of diabetes mellitus and its complications. Geneva: World Health Organization. Department of Noncommunicable Disease Surveillance Geneva; 1999. Report No.: WHO/NCD/NCS/99.2.
8.
Sobngwi E, Mauvais-Jarvis F, Vexiau P, Mbanya JC, Gautier JF. Diabetes in Africans. Part 1: epidemiology and clinical specificities. Diabetes Metab. 2001;27:628–34.PubMed
9.
Evaristo-neto AD, Foss-Freitas MC, Foss MC. Prevalence of diabetes mellitus and impaired glucose tolerance in a rural community of Angola. Diabetol Metab Syndr. 2010;2:63.PubMedCentralPubMed
10.
World Health Organization. Prevention of diabetes mellitus. Report of a WHO Study Group. Geneva: World Health organization; 1994. Report No.: 844.
11.
Adeleye JO, Abbiyesuku FM. Glucose and insulin responses in offspring of Nigerian type 2 diabetics. Afr J Med Med Sci. 2002;31:253–7.PubMed
12.
American Diabetes Association. Position statement: diagnosis and classification of diabetes mellitus. Diabetes Care. 2004;27:Suppl 1: S5–S10.
13.
World Health Organization. Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. Geneva: World Health Organization; 2010.
14.•
Otaigbe BE, Imafidon EE. Type 2 diabetes mellitus in a Nigerian child: a case report. Afr Health Sci. 2011;11:454–6. Nigerian study which provides evidence of T2DM occurring in a child. This is of importance as the current tendency is to assume T1DM in children presenting with hyperglycemia. PubMedCentralPubMed
15.
International Diabetes Federation, World Health Organization, African Union. The diabetes strategy for Africa: an integrated strategic plan for diabetes and related health risks. IDF. 2006.
16.
Barruet R, Gbadoe AD. Type 2 diabetes mellitus in children in black Africa: description of first five cases in Togo. Med Trop (Mars). 2006;66:481–3.
17.
Crowther NJ, Cameron N, Trusler J, Gray IP. Association between poor glucose tolerance and rapid post natal weight gain in seven-year-old children. Diabetologia. 1998;41:1163–7.PubMedCrossRef
18.
Yu C, Zinman B. Type2 diabetes and impaired glucose tolerance in aboriginal populations: a global perspective. Diabetes Res Clin Pract. 2007;78:159–70.PubMedCrossRef
19.
Nettleton C, et al. Symposium on the social determinants of Indigenous health. In: An overview of current knowledge of the social determinants of indigenous health. Ref Type: Pamphlet. Geneva: World Health Organization; 2007.
20.
Levitt NS, Steyn K, Lambert EV, et al. Modifiable risk factors for type 2 diabetes mellitus in a peri-urban community in South Africa. Diabetes Medicine. 1999;16:946–50.
21.
Cooper RS, Rotimi CN, Kaufman JS, Owoaje EE, Fraser H, Forrester T, et al. Prevalence of NIDDM among populations of the African diaspora. Diabetes Care. 1997;20:343–8.PubMedCrossRef
22.
Klimentidis YC, Abrams M, Wang J, Fernandez JR, Allison DB. Natural selection at genomic regions associated with obesity and type-2 diabetes: East Asians and sub-Saharan Africans exhibit high levels of differentiation at type-2 diabetes regions. Hum Genet. 2011;129:407–18.PubMedCentralPubMedCrossRef
23.
Dowse GK, Zimmet PZ, Gareeboo H, George K, Alberti MM, Tuomilehto J, et al. Abdominal obesity and physical inactivity as risk factors for NIDDM and impaired glucose tolerance in Indian, Creole, and Chinese Mauritians. Diabetes Care. 1991;14:271–82.PubMedCrossRef
24.
Kasiam LO, Longo-Mbenza B, Nge OA, Kangola KN, Mbungu FS, Milongo DG. Classification and dramatic epidemic of diabetes mellitus in Kinshasa Hinterland: the prominent role of type 2 diabetes and lifestyle changes among Africans. Niger J Med. 2009;18:311–20.PubMed
25.
Bourne LT, Lambert EV, Steyn K. Where does the black population of South Africa stand on the nutrition transition? Public Health Nutr. 2002;5:157–62.PubMedCrossRef
26.
Levitt NS, Katzenellenbogen JM, Bradshaw D, Hoffman MN, Bonnici F. The prevalence and identification of risk factors for NIDDM in urban Africans in Cape Town. S Afr Diabetes Care. 1993;16:601–7.CrossRef
27.
Rotimi CN, Cooper RS, Okosun IS, Olatunbosun ST, Bella AF, Wilks R, et al. Prevalence of diabetes and impaired glucose tolerance in Nigerians, Jamaicans and US blacks. Ethn Dis. 1999;9:190–200.PubMed
28.
Levitt NS, Katzenellenbogen JM, Bradshaw D, Hoffman MN, Bonnici F. The prevalence and identification of risk factors for NIDDM in urban Africans in Cape Town, South Africa. Diabetes Care. 1993;16:601–7.PubMedCrossRef
29.
Plantinga LC, Crews DC, Coresh J, et al. Prevalence of chronic kidney disease in US adults with undiagnosed diabetes or prediabetes. Clin J Am Soc Nephrol. 2010;5:673–82.PubMedCentralPubMedCrossRef
30.
Flores-Le Roux JA, Comin J, Pedro-Botet J, et al. Seven-year mortality in heart failure patients with undiagnosed diabetes: an observational study. Cardiovasc Diabetol. 2011;10:39.PubMedCentralPubMedCrossRef
31.
Spijkerman AMW, Dekker JM, Nijpels G, et al. Microvascular complications at time of diagnosis of type2 diabetes are similar among diabetic patients detected by targeted screening and patients newly diagnosed in general practice: the hoorn screening study. Diabetes Care. 2003;29:2604–8.CrossRef
32.
Mbanya JC, Ramiaya K. Diabetes mellitus. In: Jamison DT, Feachem RG, Makgoba MW, et al., editors. Disease and mortality in Sub-Saharan Africa. 2nd ed. Washington: World Bank; 2006.
33.
International Working Group on the Diabetic Foot. International consensus on the Diabetic Foot. International Working Group on the Diabetic Foot; 1999.
34.
Kengne AP, Djouogo CF, Dehayem MY, Fezeu L, Sobngwi E, Lekoubou A, et al. Admission trends over 8 years for diabetic foot ulceration in a specialized diabetes unit in Cameroon. Int J Low Extrem Wounds. 2009;8:180–6.PubMedCrossRef
35.•
Odusan O, Ogunsemi O, Olatawura MO. Common mental disorders among subjects with T2DM in Sagamu, Nigeria. Afr J Med Med Sci. 2012;41:141–5. This reference pays attention to the prevalence of foot ulceration as a diabetes-related complication. Diabetic foot does not currently receive sufficient attention in SSA. PubMed
36.
Lester FT. Clinical status of Ethiopian diabetic patients after 20 years of diabetes. Diabetes Med. 1991;8:272–6.CrossRef
37.
Sobngwi E, Mbanya JC, Moukouri EN, Ngu KB. Microalbuminuria and retinopathy in a diabetic population of Cameroon. Diabetes Res Clin Pract. 1999;44:191–6.PubMedCrossRef
38.••
Popkin BM. The nutrition transition and its health implications in in lower-income countries. Public Health Nutr. 2011;1:5–21. Author clearly spells out the role the nutrition transition in the current rising problem of obesity and diabetes.
39.•
Ettarh R, Van de Vijver S, Oti S, Kyobutungi C. Overweight, obesity, and perception of body image among slum residents in Nairobi, Kenya, 2008–2009. Prev Chronic Dis. 2013;10:E212. Highlights the importance of considering overweight/obesity perception in our quest to promote healthy weight maintenance. If people don’t see obesity as a problem, interventions might meet with resistance. PubMedCentralPubMedCrossRef
40.
Delisle H, Agueh V, Fayomi B. Partnership research on nutrition transition and chronic diseases in West Africa - trends, outcomes and impacts. BMC Int Health Hum Rights. 2011;11 Suppl 2:S10.PubMedCentralPubMedCrossRef
41.••
Popkin BM, Adair LS, Ng SW. Global nutrition transition and the pandemic of obesity in developing countries. Nutr Rev. 2012;70:3–21. Another publication which points out the role of the nutrition transition in the changing disease pattern. PubMedCentralPubMedCrossRef
42.
Micklesfield LK, Lambert EV, Hume DJ, Chantler S, Pienaar PR, Dickie K, et al. Socio-cultural, environmental and behavioural determinants of obesity in black South African women. Cardiovasc J Afr. 2013;24:369–75.PubMedCentralPubMedCrossRef
43.
Msyamboza KP, Kathyola D, Dzowela T. Anthropometric measurements and prevalence of underweight, overweight and obesity in adult Malawians: nationwide population based NCD STEPS survey. Pan Afr Med J. 2013;15:108.PubMedCentralPubMedCrossRef
44.
Okpechi IG, Chukwuonye II, Tiffin N, Madukwe OO, Onyeonoro UU, Umeizudike TI, et al. Blood pressure gradients and cardiovascular risk factors in urban and rural populations in Abia State South Eastern Nigeria using the WHO STEPwise approach. PLoS One. 2013;8:e73403.PubMedCentralPubMedCrossRef
45.
Lourdes DO, Plat D, Pochet P, Sahabana M. La diffusion des motos-taxi dans l'Afrique Urbaine au Sud du Sahara, XLIIIe Colloque de l'ASRDLF: Association de Science Regionale De Langue Francaise; 2007.
46.
Assah FK, Ekelund U, Brage S, Mbanya JC, Wareham NJ. Urbanization, physical activity, and metabolic health in sub-Saharan Africa. Diabetes Care. 2011;34:491–6.PubMedCentralPubMedCrossRef
47.
World Health Organization. Global status report on non-communicable diseases, 2010. Geneva: WHO; 2010.
48.
Danquah I, Bedu-Addo G, Terpe KJ, Micah F, Amoako YA, Awuku YA, et al. Diabetes mellitus type 2 in urban Ghana: characteristics and associated factors. Biomedcentral Public Health. 2012;12:210.
49.
Frank LK, Heraclides A, Danquah I, Bedu-Addo G, Mockenhaupt FP, Schulze MB. Measures of general and central obesity and risk of type 2 diabetes in a Ghanaian population. Trop Med Int Health. 2013;18:141–51.PubMedCrossRef
50.
Buresi D. Clinical study of diabetes mellitus in hospital practice in Northern Rwanda (apropos of 86 case reports). Med Trop (Mars). 1988;48:229–35.
51.
Erasmus RT, Blanco BE, Okesina AB, Gqweta Z, Matsha T. Assessment of glycaemic control in stable type 2 black South African diabetics attending a peri-urban clinic. Postgrad Med J. 1999;75:603–6.PubMedCentralPubMed
52.
Oguntibeju OO, Odunaiya N, Oladipo B, Truter EJ. Health behaviour and quality of life of patients with type 2 diabetes attending selected hospitals in south western Nigeria. West Indian Med J. 2012;61:619–26.PubMed
53.
Evaristo-neto AD, Foss-Freitas MC, Foss MC. Prevalence of diabetes mellitus and impaired glucose tolerance in a rural community of Angola. Diabetol Metab Syndr. 2010;2:63.
54.
World Health Organization. The world health report 2002. Reducing risks, promoting healthy life. Geneva: World Health Organization; 2002.
55.••
Beaglehole R, Bonita R, Alleyne G, Horton R, Li L, Lincoln P, et al. UN high-level meeting on non communicable diseases: addressing 4 questions. Lancet. 2011;378:449–55. This publication spells out the global attention that has been given NCDs as a global health challenge. PubMedCrossRef
56.
Young F, Critchley JA, Johnstone LK, Unwin NC. A review of co-morbidity between infectious and chronic disease in Sub Saharan Africa: TB and diabetes mellitus, HIV and metabolic syndrome, and the impact of globalization. Global Health. 2009;5.
57.
Hall V, Thomsen RW, Henriksen O, Lohse N. Diabetes in Sub Saharan Africa 1999–2011: epidemiology and public health implications. A systematic review. BMC Public Health. 2011;11:564.PubMedCentralPubMedCrossRef
58.
Gill GV, Mbanya JC, Ramaiya KL, Tesfaye S. A sub-Saharan African perspective of diabetes. Diabetologia. 2009;52:8–16.PubMedCrossRef
59.
World Health Organization (WHO). Preventing chronic diseases: a vital investment. Geneva: World Health Organization; 2005.
60.
61.
BeLue R, Diaw M, Ndao F, Okoror T, Degboe A, Abiero B. A cultural lens to understanding daily experiences with type 2 diabetes self-management among clinic patients in M'bour, Senegal. Int Q Community Health Educ. 2012;33:329–47.PubMedCrossRef
62.
Cameron A, Roubos I, Ewen M, Mantel-Teeuwisse AK, Leufkens HGM, Laing RO. Differences in the availability of medicines for chronic and acute conditions in the public and private sectors of developing countries. Bull World Health Organ. 2011;89:412–21.PubMedCentralPubMedCrossRef
63.
Pories WJ, Flickinger EG, Meelheim D, Van Rij AM, Thomas FT. The effectiveness of gastric bypass over gastric partition in morbid obesity. Ann Surg. 1982;196:398–9.CrossRef
64.
Naslund I, Wickbom G, Christofferson E, Agren G. A prospective randomized comparison of gastric bypass and gastro-plasty: complications and early results. Acta Chir Scand. 1986;152:681–9.PubMed
65.
Hall JC, Watts JM, O'Brien PE, Dustan RE, Walsh JF, Slavotinek AH, et al. Gastric surgery for morbid obesity: the Adelaide study. Ann Surg. 2014;211:419–27.CrossRef
66.
World Health Assembly. Follow-up to the political declaration of the high-level meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases. Geneva: WHO; 2013.
67.
Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20:537–44.PubMedCrossRef
68.
Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by change in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343–50.PubMedCrossRef
69.
Vijan S, Stevens D, Hermann W, Funnell M, Strandiford C. Screening, prevention, counselling, and treatment for the complications of type ii diabetes mellitus. Putting evidence into practice. J Gen Int Med. 1997;12:567–80.CrossRef
70.
Wojtaszewski JF, Hansen BF, Gade J, Kiens B, Markuns JF, Goodyear LJ, et al. Insulin signaling and sensitivity after exercise in human skeletal muscle. Diabetes. 2000;49:325–31.PubMedCrossRef
71.
Gogo-Jack S. Primary prevention of type-2 diabetes in developing countries. J Natl Med Assoc. 2006;98:415–9.
72.•
Vorster HH, Kruger A, Margetts BM. The nutrition transition in Africa: can it be steered into a more positive direction? Nutrients. 2011;3:429–41. Provides an interesting idea involving the steering of the nutrition transition to a more favorable transition. PubMedCentralPubMedCrossRef
73.
Schwarz PH, Li J, Lindstrom J, Tuomilehto J. Tools for predicting the risk of type 2 diabetes in daily practice. Horm Metab Res. 2009;41:86–97.PubMedCrossRef
Metadata
Title
Obesity and Type 2 Diabetes in Sub-Sahara Africa
Authors
Jean Claude Mbanya
Felix K. Assah
Jude Saji
Emmanuella N. Atanga
Publication date
01-07-2014
Publisher
Springer US
Published in
Current Diabetes Reports / Issue 7/2014
Print ISSN: 1534-4827
Electronic ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-014-0501-5

Other articles of this Issue 7/2014

Current Diabetes Reports 7/2014 Go to the issue

Macrovascular Complications in Diabetes (L Perreault, Section Editor)

Metabolic Consequences of Sleep and Circadian Disorders

Diabetes and Other Diseases-Emerging Associations (JJ Nolan, Section Editor)

Is There an Effect of Glucose Lowering Treatment on Incidence and Prognosis of Tuberculosis? A Systematic Review

Health Care Delivery Systems in Diabetes (D Wexler, Section Editor)

A Review of Recent Literature - Nurse Case Managers in Diabetes Care: Equivalent or Better Outcomes Compared to Primary Care Providers

Transplantation (A Pileggi, Section Editor)

Stem Cell Therapies in the Management of Diabetic Retinopathy

Diabetes and Pregnancy (CJ Homko, Section Editor)

Diabetes in Pregnancy: Timing and Mode of Delivery

Macrovascular Complications in Diabetes (L Perreault, Section Editor)

Look Inside Look AHEAD: Why the Glass Is More than Half-Full
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits